Pancreatic ductal adenocarcinoma cells employ integrin α6β4 to form hemidesmosomes and regulate cell proliferation. 2022

Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
Wellcome Centre for Cell-Matrix Research, Faculty of Biology, Medicine & Health, Manchester Academic Health Science Centre, University of Manchester, Oxford Road, Manchester M13 9PT, UK.

Pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis due to its aggressive progression, late detection and lack of druggable driver mutations, which often combine to result in unsuitability for surgical intervention. Together with activating mutations of the small GTPase KRas, which are found in over 90% of PDAC tumours, a contributory factor for PDAC tumour progression is formation of a rigid extracellular matrix (ECM) and associated desmoplasia. This response leads to aberrant integrin signalling, and accelerated proliferation and invasion. To identify the integrin adhesion systems that operate in PDAC, we analysed a range of pancreatic ductal epithelial cell models using 2D, 3D and organoid culture systems. Proteomic analysis of isolated integrin receptor complexes from human pancreatic ductal epithelial (HPDE) cells predominantly identified integrin α6β4 and hemidesmosome components, rather than classical focal adhesion components. Electron microscopy, together with immunofluorescence, confirmed the formation of hemidesmosomes by HPDE cells, both in 2D and 3D culture systems. Similar results were obtained for the human PDAC cell line, SUIT-2. Analysis of HPDE cell secreted proteins and cell-derived matrices (CDM) demonstrated that HPDE cells secrete a range of laminin subunits and form a hemidesmosome-specific, laminin 332-enriched ECM. Expression of mutant KRas (G12V) did not affect hemidesmosome composition or formation by HPDE cells. Cell-ECM contacts formed by mouse and human PDAC organoids were also assessed by electron microscopy. Organoids generated from both the PDAC KPC mouse model and human patient-derived PDAC tissue displayed features of acinar-ductal cell polarity, and hemidesmosomes were visible proximal to prominent basement membranes. Furthermore, electron microscopy identified hemidesmosomes in normal human pancreas. Depletion of integrin β4 reduced cell proliferation in both SUIT-2 and HPDE cells, reduced the number of SUIT-2 cells in S-phase, and induced G1 cell cycle arrest, suggesting a requirement for α6β4-mediated adhesion for cell cycle progression and growth. Taken together, these data suggest that laminin-binding adhesion mechanisms in general, and hemidesmosome-mediated adhesion in particular, may be under-appreciated in the context of PDAC. Proteomic data are available via ProteomeXchange with the identifiers PXD027803, PXD027823 and PXD027827.

UI MeSH Term Description Entries
D007797 Laminin Large, noncollagenous glycoprotein with antigenic properties. It is localized in the basement membrane lamina lucida and functions to bind epithelial cells to the basement membrane. Evidence suggests that the protein plays a role in tumor invasion. Merosin,Glycoprotein GP-2,Laminin M,Laminin M Chain,Chain, Laminin M,Glycoprotein GP 2,M Chain, Laminin
D010190 Pancreatic Neoplasms Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA). Cancer of Pancreas,Pancreatic Cancer,Cancer of the Pancreas,Neoplasms, Pancreatic,Pancreas Cancer,Pancreas Neoplasms,Pancreatic Acinar Carcinoma,Pancreatic Carcinoma,Acinar Carcinoma, Pancreatic,Acinar Carcinomas, Pancreatic,Cancer, Pancreas,Cancer, Pancreatic,Cancers, Pancreas,Cancers, Pancreatic,Carcinoma, Pancreatic,Carcinoma, Pancreatic Acinar,Carcinomas, Pancreatic,Carcinomas, Pancreatic Acinar,Neoplasm, Pancreas,Neoplasm, Pancreatic,Neoplasms, Pancreas,Pancreas Cancers,Pancreas Neoplasm,Pancreatic Acinar Carcinomas,Pancreatic Cancers,Pancreatic Carcinomas,Pancreatic Neoplasm
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016283 Proto-Oncogene Proteins p21(ras) Cellular proteins encoded by the H-ras, K-ras and N-ras genes. The proteins have GTPase activity and are involved in signal transduction as monomeric GTP-binding proteins. Elevated levels of p21 c-ras have been associated with neoplasia. This enzyme was formerly listed as EC 3.6.1.47. Proto-Oncogene Proteins c-ras,c-Ha-ras p21,c-Ki-ras p21,p21(N-ras),p21(c-Ha-ras),p21(c-Ki-ras),p21(c-ras),p21(ras),ras Proto-Oncogene Protein p21,Proto-Oncogene Protein p21(c-Ha-ras),Proto-Oncogene Protein p21(c-Ki-ras),Proto-Oncogene Protein p21(c-N-ras),Proto-Oncogene Protein p21(ras),Proto-Oncogene Protein ras,c-ras Proteins,p21 c-H-ras,p21 c-Ha-ras,p21 c-K-ras,p21 c-Ki-ras,p21 c-ras,ras Proto-Oncogene Product p21,Proteins c-ras, Proto-Oncogene,Proto Oncogene Protein ras,Proto Oncogene Proteins c ras,c Ha ras p21,c Ki ras p21,c ras Proteins,c-H-ras, p21,c-Ha-ras, p21,c-K-ras, p21,c-Ki-ras, p21,c-ras, Proto-Oncogene Proteins,c-ras, p21,p21 c H ras,p21 c Ha ras,p21 c K ras,p21 c Ki ras,p21 c ras,p21, c-Ha-ras,p21, c-Ki-ras,ras Proto Oncogene Product p21,ras Proto Oncogene Protein p21,ras, Proto-Oncogene Protein
D049109 Cell Proliferation All of the processes involved in increasing CELL NUMBER including CELL DIVISION. Cell Growth in Number,Cellular Proliferation,Cell Multiplication,Cell Number Growth,Growth, Cell Number,Multiplication, Cell,Number Growth, Cell,Proliferation, Cell,Proliferation, Cellular
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D021441 Carcinoma, Pancreatic Ductal Carcinoma that arises from the PANCREATIC DUCTS. It accounts for the majority of cancers derived from the PANCREAS. Pancreatic Ductal Carcinoma,Carcinoma, Ductal, Pancreatic,Duct-Cell Carcinoma of the Pancreas,Duct-Cell Carcinoma, Pancreas,Ductal Carcinoma of the Pancreas,Pancreatic Duct Cell Carcinoma,Carcinoma, Pancreas Duct-Cell,Carcinomas, Pancreas Duct-Cell,Carcinomas, Pancreatic Ductal,Duct Cell Carcinoma of the Pancreas,Duct Cell Carcinoma, Pancreas,Duct-Cell Carcinomas, Pancreas,Ductal Carcinoma, Pancreatic,Ductal Carcinomas, Pancreatic,Pancreas Duct-Cell Carcinoma,Pancreas Duct-Cell Carcinomas,Pancreatic Ductal Carcinomas
D022002 Hemidesmosomes An anchoring junction of the cell to a non-cellular substrate, similar in morphology to halves of DESMOSOMES. They are composed of specialized areas of the plasma membrane where INTERMEDIATE FILAMENTS bind on the cytoplasmic face to the transmembrane linkers, INTEGRINS, via intracellular attachment proteins, while the extracellular domain of the integrins binds to EXTRACELLULAR MATRIX PROTEINS. Hemidesmosome
D039161 Integrin alpha6beta4 This intrgrin is a key component of HEMIDESMOSOMES and is required for their formation and maintenance in epithelial cells. Integrin alpha6beta4 is also found on thymocytes, fibroblasts, and Schwann cells, where it functions as a laminin receptor (RECEPTORS, LAMININ) and is involved in wound healing, cell migration, and tumor invasiveness. A9 Antigen,Integrin alpha(6),beta(4),Laminin-5 Receptor (alpha6beta4 Integrin),TSP-180,Tumor Specific Protein-180 Complex,alpha(6)beta(4) Epithelial Integrin,alpha(6)beta(4) Integrin,alpha6 beta4 Integrin,Antigen, A9,Integrin, alpha6 beta4,Tumor Specific Protein 180 Complex,alpha6beta4, Integrin,beta4 Integrin, alpha6

Related Publications

Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
September 2023, Cancer research communications,
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
January 2015, Cancer cell international,
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
January 2022, Frontiers in cell and developmental biology,
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
November 2023, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.],
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
July 2018, Journal of cell science,
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
April 2015, Oncology reports,
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
April 2019, Cancer research,
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
January 2016, Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.],
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
December 2010, Anticancer research,
Jonathan D Humphries, and Junzhe Zha, and Jessica Burns, and Janet A Askari, and Christopher R Below, and Megan R Chastney, and Matthew C Jones, and Aleksandr Mironov, and David Knight, and Derek A O'Reilly, and Mark J Dunne, and David R Garrod, and Claus Jorgensen, and Martin J Humphries
February 2015, Biochemical and biophysical research communications,
Copied contents to your clipboard!